1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Liquid Form 1.2.3 Lyophilized Powder Form 1.3 Market by Application 1.3.1 Global Intravenous Immune Globulin Therapies Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Immunodeficiency 1.3.3 Autoimmune Disease 1.3.4 Acute Infection 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Intravenous Immune Globulin Therapies Market Perspective (2018-2029) 2.2 Intravenous Immune Globulin Therapies Growth Trends by Region 2.2.1 Global Intravenous Immune Globulin Therapies Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Intravenous Immune Globulin Therapies Historic Market Size by Region (2018-2023) 2.2.3 Intravenous Immune Globulin Therapies Forecasted Market Size by Region (2024-2029) 2.3 Intravenous Immune Globulin Therapies Market Dynamics 2.3.1 Intravenous Immune Globulin Therapies Industry Trends 2.3.2 Intravenous Immune Globulin Therapies Market Drivers 2.3.3 Intravenous Immune Globulin Therapies Market Challenges 2.3.4 Intravenous Immune Globulin Therapies Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Intravenous Immune Globulin Therapies Players by Revenue 3.1.1 Global Top Intravenous Immune Globulin Therapies Players by Revenue (2018-2023) 3.1.2 Global Intravenous Immune Globulin Therapies Revenue Market Share by Players (2018-2023) 3.2 Global Intravenous Immune Globulin Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Intravenous Immune Globulin Therapies Revenue 3.4 Global Intravenous Immune Globulin Therapies Market Concentration Ratio 3.4.1 Global Intravenous Immune Globulin Therapies Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Intravenous Immune Globulin Therapies Revenue in 2022 3.5 Intravenous Immune Globulin Therapies Key Players Head office and Area Served 3.6 Key Players Intravenous Immune Globulin Therapies Product Solution and Service 3.7 Date of Enter into Intravenous Immune Globulin Therapies Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Intravenous Immune Globulin Therapies Breakdown Data by Type 4.1 Global Intravenous Immune Globulin Therapies Historic Market Size by Type (2018-2023) 4.2 Global Intravenous Immune Globulin Therapies Forecasted Market Size by Type (2024-2029) 5 Intravenous Immune Globulin Therapies Breakdown Data by Application 5.1 Global Intravenous Immune Globulin Therapies Historic Market Size by Application (2018-2023) 5.2 Global Intravenous Immune Globulin Therapies Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Intravenous Immune Globulin Therapies Market Size (2018-2029) 6.2 North America Intravenous Immune Globulin Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Intravenous Immune Globulin Therapies Market Size by Country (2018-2023) 6.4 North America Intravenous Immune Globulin Therapies Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Intravenous Immune Globulin Therapies Market Size (2018-2029) 7.2 Europe Intravenous Immune Globulin Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Intravenous Immune Globulin Therapies Market Size by Country (2018-2023) 7.4 Europe Intravenous Immune Globulin Therapies Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Intravenous Immune Globulin Therapies Market Size (2018-2029) 8.2 Asia-Pacific Intravenous Immune Globulin Therapies Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Intravenous Immune Globulin Therapies Market Size by Region (2018-2023) 8.4 Asia-Pacific Intravenous Immune Globulin Therapies Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Intravenous Immune Globulin Therapies Market Size (2018-2029) 9.2 Latin America Intravenous Immune Globulin Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Intravenous Immune Globulin Therapies Market Size by Country (2018-2023) 9.4 Latin America Intravenous Immune Globulin Therapies Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Intravenous Immune Globulin Therapies Market Size (2018-2029) 10.2 Middle East & Africa Intravenous Immune Globulin Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Country (2018-2023) 10.4 Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 Baxter 11.1.1 Baxter Company Detail 11.1.2 Baxter Business Overview 11.1.3 Baxter Intravenous Immune Globulin Therapies Introduction 11.1.4 Baxter Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) 11.1.5 Baxter Recent Development 11.2 Grifols 11.2.1 Grifols Company Detail 11.2.2 Grifols Business Overview 11.2.3 Grifols Intravenous Immune Globulin Therapies Introduction 11.2.4 Grifols Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) 11.2.5 Grifols Recent Development 11.3 CSL Plasma 11.3.1 CSL Plasma Company Detail 11.3.2 CSL Plasma Business Overview 11.3.3 CSL Plasma Intravenous Immune Globulin Therapies Introduction 11.3.4 CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) 11.3.5 CSL Plasma Recent Development 11.4 Octapharma 11.4.1 Octapharma Company Detail 11.4.2 Octapharma Business Overview 11.4.3 Octapharma Intravenous Immune Globulin Therapies Introduction 11.4.4 Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) 11.4.5 Octapharma Recent Development 11.5 Biotest 11.5.1 Biotest Company Detail 11.5.2 Biotest Business Overview 11.5.3 Biotest Intravenous Immune Globulin Therapies Introduction 11.5.4 Biotest Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) 11.5.5 Biotest Recent Development 11.6 Kedrion 11.6.1 Kedrion Company Detail 11.6.2 Kedrion Business Overview 11.6.3 Kedrion Intravenous Immune Globulin Therapies Introduction 11.6.4 Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) 11.6.5 Kedrion Recent Development 11.7 Kamada 11.7.1 Kamada Company Detail 11.7.2 Kamada Business Overview 11.7.3 Kamada Intravenous Immune Globulin Therapies Introduction 11.7.4 Kamada Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) 11.7.5 Kamada Recent Development 11.8 China Biologic Products Holdings 11.8.1 China Biologic Products Holdings Company Detail 11.8.2 China Biologic Products Holdings Business Overview 11.8.3 China Biologic Products Holdings Intravenous Immune Globulin Therapies Introduction 11.8.4 China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) 11.8.5 China Biologic Products Holdings Recent Development 11.9 Hualan Biological Engineering 11.9.1 Hualan Biological Engineering Company Detail 11.9.2 Hualan Biological Engineering Business Overview 11.9.3 Hualan Biological Engineering Intravenous Immune Globulin Therapies Introduction 11.9.4 Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) 11.9.5 Hualan Biological Engineering Recent Development 11.10 Sichuan Yuanda Shuyang Pharmaceutical 11.10.1 Sichuan Yuanda Shuyang Pharmaceutical Company Detail 11.10.2 Sichuan Yuanda Shuyang Pharmaceutical Business Overview 11.10.3 Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Introduction 11.10.4 Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) 11.10.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Liquid Form Table 3. Key Players of Lyophilized Powder Form Table 4. Global Intravenous Immune Globulin Therapies Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 5. Global Intravenous Immune Globulin Therapies Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 6. Global Intravenous Immune Globulin Therapies Market Size by Region (2018-2023) & (US$ Million) Table 7. Global Intravenous Immune Globulin Therapies Market Share by Region (2018-2023) Table 8. Global Intravenous Immune Globulin Therapies Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 9. Global Intravenous Immune Globulin Therapies Market Share by Region (2024-2029) Table 10. Intravenous Immune Globulin Therapies Market Trends Table 11. Intravenous Immune Globulin Therapies Market Drivers Table 12. Intravenous Immune Globulin Therapies Market Challenges Table 13. Intravenous Immune Globulin Therapies Market Restraints Table 14. Global Intravenous Immune Globulin Therapies Revenue by Players (2018-2023) & (US$ Million) Table 15. Global Intravenous Immune Globulin Therapies Market Share by Players (2018-2023) Table 16. Global Top Intravenous Immune Globulin Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immune Globulin Therapies as of 2022) Table 17. Ranking of Global Top Intravenous Immune Globulin Therapies Companies by Revenue (US$ Million) in 2022 Table 18. Global 5 Largest Players Market Share by Intravenous Immune Globulin Therapies Revenue (CR5 and HHI) & (2018-2023) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Intravenous Immune Globulin Therapies Product Solution and Service Table 21. Date of Enter into Intravenous Immune Globulin Therapies Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Intravenous Immune Globulin Therapies Market Size by Type (2018-2023) & (US$ Million) Table 24. Global Intravenous Immune Globulin Therapies Revenue Market Share by Type (2018-2023) Table 25. Global Intravenous Immune Globulin Therapies Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 26. Global Intravenous Immune Globulin Therapies Revenue Market Share by Type (2024-2029) Table 27. Global Intravenous Immune Globulin Therapies Market Size by Application (2018-2023) & (US$ Million) Table 28. Global Intravenous Immune Globulin Therapies Revenue Market Share by Application (2018-2023) Table 29. Global Intravenous Immune Globulin Therapies Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 30. Global Intravenous Immune Globulin Therapies Revenue Market Share by Application (2024-2029) Table 31. North America Intravenous Immune Globulin Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 32. North America Intravenous Immune Globulin Therapies Market Size by Country (2018-2023) & (US$ Million) Table 33. North America Intravenous Immune Globulin Therapies Market Size by Country (2024-2029) & (US$ Million) Table 34. Europe Intravenous Immune Globulin Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 35. Europe Intravenous Immune Globulin Therapies Market Size by Country (2018-2023) & (US$ Million) Table 36. Europe Intravenous Immune Globulin Therapies Market Size by Country (2024-2029) & (US$ Million) Table 37. Asia-Pacific Intravenous Immune Globulin Therapies Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 38. Asia-Pacific Intravenous Immune Globulin Therapies Market Size by Region (2018-2023) & (US$ Million) Table 39. Asia-Pacific Intravenous Immune Globulin Therapies Market Size by Region (2024-2029) & (US$ Million) Table 40. Latin America Intravenous Immune Globulin Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 41. Latin America Intravenous Immune Globulin Therapies Market Size by Country (2018-2023) & (US$ Million) Table 42. Latin America Intravenous Immune Globulin Therapies Market Size by Country (2024-2029) & (US$ Million) Table 43. Middle East & Africa Intravenous Immune Globulin Therapies Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 44. Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Country (2018-2023) & (US$ Million) Table 45. Middle East & Africa Intravenous Immune Globulin Therapies Market Size by Country (2024-2029) & (US$ Million) Table 46. Baxter Company Detail Table 47. Baxter Business Overview Table 48. Baxter Intravenous Immune Globulin Therapies Product Table 49. Baxter Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) & (US$ Million) Table 50. Baxter Recent Development Table 51. Grifols Company Detail Table 52. Grifols Business Overview Table 53. Grifols Intravenous Immune Globulin Therapies Product Table 54. Grifols Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) & (US$ Million) Table 55. Grifols Recent Development Table 56. CSL Plasma Company Detail Table 57. CSL Plasma Business Overview Table 58. CSL Plasma Intravenous Immune Globulin Therapies Product Table 59. CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) & (US$ Million) Table 60. CSL Plasma Recent Development Table 61. Octapharma Company Detail Table 62. Octapharma Business Overview Table 63. Octapharma Intravenous Immune Globulin Therapies Product Table 64. Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) & (US$ Million) Table 65. Octapharma Recent Development Table 66. Biotest Company Detail Table 67. Biotest Business Overview Table 68. Biotest Intravenous Immune Globulin Therapies Product Table 69. Biotest Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) & (US$ Million) Table 70. Biotest Recent Development Table 71. Kedrion Company Detail Table 72. Kedrion Business Overview Table 73. Kedrion Intravenous Immune Globulin Therapies Product Table 74. Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) & (US$ Million) Table 75. Kedrion Recent Development Table 76. Kamada Company Detail Table 77. Kamada Business Overview Table 78. Kamada Intravenous Immune Globulin Therapies Product Table 79. Kamada Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) & (US$ Million) Table 80. Kamada Recent Development Table 81. China Biologic Products Holdings Company Detail Table 82. China Biologic Products Holdings Business Overview Table 83. China Biologic Products Holdings Intravenous Immune Globulin Therapies Product Table 84. China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) & (US$ Million) Table 85. China Biologic Products Holdings Recent Development Table 86. Hualan Biological Engineering Company Detail Table 87. Hualan Biological Engineering Business Overview Table 88. Hualan Biological Engineering Intravenous Immune Globulin Therapies Product Table 89. Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) & (US$ Million) Table 90. Hualan Biological Engineering Recent Development Table 91. Sichuan Yuanda Shuyang Pharmaceutical Company Detail Table 92. Sichuan Yuanda Shuyang Pharmaceutical Business Overview Table 93. Sichuan Yuanda Shuyang Pharmaceutical Intravenous Immune Globulin Therapies Product Table 94. Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2018-2023) & (US$ Million) Table 95. Sichuan Yuanda Shuyang Pharmaceutical Recent Development Table 96. Research Programs/Design for This Report Table 97. Key Data Information from Secondary Sources Table 98. Key Data Information from Primary Sources List of Figures Figure 1. Global Intravenous Immune Globulin Therapies Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Intravenous Immune Globulin Therapies Market Share by Type: 2022 VS 2029 Figure 3. Liquid Form Features Figure 4. Lyophilized Powder Form Features Figure 5. Global Intravenous Immune Globulin Therapies Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 6. Global Intravenous Immune Globulin Therapies Market Share by Application: 2022 VS 2029 Figure 7. Immunodeficiency Case Studies Figure 8. Autoimmune Disease Case Studies Figure 9. Acute Infection Case Studies Figure 10. Intravenous Immune Globulin Therapies Report Years Considered Figure 11. Global Intravenous Immune Globulin Therapies Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 12. Global Intravenous Immune Globulin Therapies Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 13. Global Intravenous Immune Globulin Therapies Market Share by Region: 2022 VS 2029 Figure 14. Global Intravenous Immune Globulin Therapies Market Share by Players in 2022 Figure 15. Global Top Intravenous Immune Globulin Therapies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immune Globulin Therapies as of 2022) Figure 16. The Top 10 and 5 Players Market Share by Intravenous Immune Globulin Therapies Revenue in 2022 Figure 17. North America Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 18. North America Intravenous Immune Globulin Therapies Market Share by Country (2018-2029) Figure 19. United States Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. Canada Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. Europe Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Europe Intravenous Immune Globulin Therapies Market Share by Country (2018-2029) Figure 23. Germany Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. France Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. U.K. Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. Italy Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. Russia Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Nordic Countries Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Asia-Pacific Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Asia-Pacific Intravenous Immune Globulin Therapies Market Share by Region (2018-2029) Figure 31. China Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Japan Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. South Korea Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Southeast Asia Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. India Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Australia Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Latin America Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Latin America Intravenous Immune Globulin Therapies Market Share by Country (2018-2029) Figure 39. Mexico Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Brazil Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Middle East & Africa Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Middle East & Africa Intravenous Immune Globulin Therapies Market Share by Country (2018-2029) Figure 43. Turkey Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Saudi Arabia Intravenous Immune Globulin Therapies Market Size YoY Growth (2018-2029) & (US$ Million) Figure 45. Baxter Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2018-2023) Figure 46. Grifols Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2018-2023) Figure 47. CSL Plasma Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2018-2023) Figure 48. Octapharma Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2018-2023) Figure 49. Biotest Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2018-2023) Figure 50. Kedrion Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2018-2023) Figure 51. Kamada Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2018-2023) Figure 52. China Biologic Products Holdings Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2018-2023) Figure 53. Hualan Biological Engineering Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2018-2023) Figure 54. Sichuan Yuanda Shuyang Pharmaceutical Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2018-2023) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Baxter Grifols CSL Plasma Octapharma Biotest Kedrion Kamada China Biologic Products Holdings Hualan Biological Engineering Sichuan Yuanda Shuyang Pharmaceutical